iScience · 2022 · 25 citations · 61 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationInnate ImmunityAnti-inflammatory PharmacologyAntiviral ImmunityInflammatory Response RegulationInflammatory SignalingInnate Immune ResponseInnate Immune Signaling PathwaysAnti-inflammatory MechanismsAnti-inflammatory TherapeuticsInnate Immunity PathwaysNf-κb SignalingNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingRaft-dependent TraffickingSars-cov-2 Infection
Among these, we show that Auranofin prevents post-translational modifications of NF-κB effectors and their recruitment into activating complexes in response to SARS-CoV-2 infection or cytokine stimulation. In addition, we demonstrate that Auranofin counteracts several steps of SARS-CoV-2 infection. First, it inhibits a raft-dependent endocytic pathway involved in SARS-CoV-2 entry into host cells; Second, Auranofin alters the ACE2 mobility at the plasma membrane. Overall, Auranofin should prevent SARS-CoV-2 infection and inflammatory damages, offering new opportunities as a repurposable drug candidate to treat COVID-19.
61
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti‐Castelvetri, Ravi Ojha, Liliana D. Pedro et al. · Science · 2020 · 2K citations · Full text